Shierley Widjaja
Directeur/Membre du Conseil chez Prometheus Laboratories, Inc.
Profil
Shierley Widjaja is currently a Director at Prometheus Laboratories, Inc. She previously worked as a Director at Prometheus Biosciences, Inc. and as a Qualitative Research Associate at McKinley Capital Management LLC from 2010 to 2017.
Widjaja received her undergraduate degree from the University of California, Los Angeles in 2005 and her MBA from The Wharton School of the University of Pennsylvania in 2010.
Postes actifs de Shierley Widjaja
| Sociétés | Poste | Début |
|---|---|---|
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Shierley Widjaja
| Sociétés | Poste | Fin |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 17/02/2021 |
McKinley Capital Management LLC
 McKinley Capital Management LLC Investment ManagersFinance McKinley Capital Management LLC (McKinley Capital) is a SEC-registered investment headquartered in Anchorage, Alaska. The firm was founded by Robert “Bob” Gillam in 1990 and is wholly-owned by McKinley Management, Inc. McKinley Capital provides investment advisory and sub-advisory services to institutional, individual and high-net worth investors. They also participate as a sub-advisor in various wrap fee programs and provide emulation or model portfolios to clients. In addition, the firm is the general partner and/or investment advisor to various commingled investment funds such as offshore and onshore limited partnerships and a statutory trust. | Analyst-Equity | 01/01/2017 |
Formation de Shierley Widjaja
| University of California, Los Angeles | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
McKinley Capital Management LLC
McKinley Capital Management LLC Investment ManagersFinance McKinley Capital Management LLC (McKinley Capital) is a SEC-registered investment headquartered in Anchorage, Alaska. The firm was founded by Robert “Bob” Gillam in 1990 and is wholly-owned by McKinley Management, Inc. McKinley Capital provides investment advisory and sub-advisory services to institutional, individual and high-net worth investors. They also participate as a sub-advisor in various wrap fee programs and provide emulation or model portfolios to clients. In addition, the firm is the general partner and/or investment advisor to various commingled investment funds such as offshore and onshore limited partnerships and a statutory trust. | Finance |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
